Reidar Rasmussen, Labmodul

Why are you going to Scanlab and Biotech Forum?

Hey Johannes Hedman...

... graduate of SKL and LTH, who has improved a method of forensic analysis

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established regulations stating that pharmaceuticals must be tested for children as well as for adults.

How to get the most out of the fair

375 miljoner till cancerforskare

Cancerfonden ger Ruth Palmer pengar för forskning på signalöverföring och ett av de största anslagen går till forskning om genexpression. Även projekt inom bland annat farmakologi, cellsignalering och strålning får tillskott.

820 miljoner till medicinsk forskning

359 projekt inom området för medicin får pengar från Vetenskapsrådet i år. I snitt kammar varje projekt hem 670 000 kronor i årets runda.

Vinnova ger miljoner till svensk-indiska projekt

Tillsammans med indiska Department of Biotechnology kommer Vinnova att satsa pengar på tuberkulosforskning. Vinnova räknar med att bidra med 16 miljoner till den svenska delen av projekten.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Teams up with leading dermatologist

Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Test if you carry the fat virus

In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.

New study of toxins and heart disease

Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study will try to evaluate this, and one thousand people are to be included.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Vitamin D is mental health aid

Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.